insulin novonordisk actrapid hm 100 ie/ml solution injectable
novo nordisk pharma ag - insulinum de l'homme adnr soluble - solution injectable - insulinum humanum adnr solutum 100 u.i., glycerolum, zincum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk insulatard hm 100 ie/ml suspension injectable
novo nordisk pharma ag - insulinum humanum adnr isophanum - suspension injectable - insulinum humanum adnr isophanum 100 u.i., protamini sulfas, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 1.5 mg, phenolum 0.65 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk actrapid hm 100 ie/ml penfill 3 solution injectable
novo nordisk pharma ag - insulinum de l'homme adnr soluble - solution injectable - insulinum humanum adnr solutum 100 u.i., glycerolum, zincum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk insulatard hm 100 ie/ml penfill 3 suspension injectable
novo nordisk pharma ag - insulinum humanum adnr isophanum - suspension injectable - insulinum humanum adnr isophanum 100 u.i., protamini sulfas, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 1.5 mg, phenolum 0.65 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk novorapid solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika
insulin novonordisk novorapid penfill solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika
insulin novonordisk novomix 30 penfill suspension injectable
novo nordisk pharma ag - insulinum aspartum - suspension injectable - insulinum aspartum 100 u., insulinum soluble 30 % et insulinum isophanum 70 %, protamini sulfamidés, le zinc comme zinci chloridum, glycerolum, natrii chloridum, natrii phosphates ou, conserv.: phenolum 1.50 mg, metacresolum 1,72 mg, de l'eau à iniectabilia q.s. à la suspension pour 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk novorapid flexpen solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u.i., corresp. 3.5 mg, glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, phenolum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika
insulin novonordisk novomix 30 flexpen suspension injectable
novo nordisk pharma ag - insulinum aspartum - suspension injectable - insulinum aspartum 100 u., insulinum soluble 30 % et insulinum isophanum 70 %, protamini sulfamidés, le zinc comme zinci chloridum, glycerolum, natrii chloridum, natrii phosphates ou, conserv.: phenolum 1.50 mg, metacresolum 1,72 mg, de l'eau à iniectabilia q.s. à la suspension pour 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk insulatard hm flexpen suspension injectable
novo nordisk pharma ag - insulinum humanum adnr isophanum - suspension injectable - insulinum humanum adnr isophanum 100 u.i., protamini sulfas, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 1.5 mg, phenolum 0.65 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - le diabète sucré - biotechnologika